Category: Top Story
-
Dollar Holds Ground After Powell’s Hawkish Tone; Euro Edges Higher Post-ECB
The U.S. dollar traded slightly higher on Friday, maintaining its strength after Federal Reserve Chair Jerome Powell’s latest remarks dampened hopes for another imminent rate cut. The euro also firmed, supported by the European Central Bank’s steady policy stance. At 05:10 ET (09:10 GMT), the Dollar Index, which measures the greenback’s value against six major…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, Markets Lifted by Amazon and Apple Earnings as China’s Factory Activity Weakens
U.S. stock futures ticked higher on Friday, signaling a positive finish to October as investors welcomed upbeat earnings from Amazon (NASDAQ:AMZN) and Apple (NASDAQ:AAPL). Meanwhile, Nvidia (NASDAQ:NVDA) unveiled a major AI chip deal with South Korea, and fresh data showed that China’s factory activity contracted more sharply than expected. U.S. futures edge higher At 02:20…
-
Comcast beats Q3 forecasts as wireless strength offsets broadband losses
Comcast Corporation (NASDAQ:CMCSA) posted better-than-expected third-quarter results, with strong gains in its wireless and entertainment divisions helping cushion ongoing broadband subscriber declines. Shares rose 1.5% in premarket trading following the release. The company reported adjusted earnings of $1.12 per share, two cents above analyst estimates, while revenue reached $31.2 billion, topping the $30.7 billion consensus…
-
Crocs shares soar nearly 10% after Q3 earnings and revenue beat forecasts
Crocs Inc. (NASDAQ:CROX) shares jumped 9.7% on Thursday after the casual footwear company delivered third-quarter results that handily beat analyst estimates, even as overall sales declined from a year earlier. The company reported adjusted earnings of $2.92 per share, far exceeding the consensus forecast of $2.36, while revenue reached $996.3 million, topping expectations of $961.61…
-
BorgWarner shares gain 2% after strong Q3 earnings beat and raised 2025 outlook
BorgWarner Inc. (NYSE:BWA) shares rose 2.5% in premarket trading Thursday after the auto parts manufacturer reported stronger-than-expected third-quarter earnings and raised its full-year guidance, despite revenue landing just shy of forecasts. The company posted adjusted earnings of $1.24 per share, topping analyst estimates of $1.17 and up 14% year-over-year. Revenue climbed 4.1% to $3.59 billion,…
-
Omnicell shares climb 4% after strong Q3 beat and raised 2025 outlook
Omnicell, Inc. (NASDAQ:OMCL) shares gained 4.19% in premarket trading Thursday after the healthcare technology company delivered better-than-expected third-quarter results and lifted its full-year guidance on the back of strong demand for its connected medication management systems. The company reported adjusted earnings of $0.51 per share, well above the analyst estimate of $0.36, while revenue reached…
-
Biogen shares drop as full-year guidance cut outweighs strong Q3 results
Biogen Inc. (NASDAQ:BIIB) shares fell 2.6% on Thursday after the biotechnology company trimmed its full-year earnings forecast, overshadowing an otherwise strong third-quarter earnings beat that topped Wall Street estimates on both profit and revenue. The company reported adjusted earnings of $4.81 per share, comfortably above the analyst consensus of $3.88, while revenue reached $2.53 billion,…
-
Bristol-Myers Squibb lifts annual outlook after topping Q3 forecasts
Bristol-Myers Squibb (NYSE:BMY) raised its full-year outlook on Thursday after delivering third-quarter results that exceeded analyst expectations, supported by robust sales from its expanding Growth Portfolio. The pharmaceutical giant reported earnings of $1.63 per share, beating the consensus estimate of $1.52, while revenue rose 3% to $12.2 billion, ahead of forecasts calling for $11.8 billion.…
-
L3Harris Technologies tops Q3 estimates, lifts full-year outlook on strong defense demand
L3Harris Technologies (NYSE:LHX) posted better-than-expected third-quarter results on Thursday, driven by solid organic revenue growth and margin improvement, prompting the defense contractor to raise its full-year 2025 guidance. Shares were up 0.7% in premarket trading following the announcement. The company reported adjusted earnings of $2.70 per share, topping the analyst consensus of $2.59, while revenue…
-
Integra LifeSciences tops profit estimates but trims outlook after revenue shortfall
Integra LifeSciences Holdings Corporation (NASDAQ:IART) posted stronger-than-expected third-quarter earnings on Thursday, but revenue missed forecasts and the company lowered its forward guidance, sending shares down 2.79% in premarket trading. The medical technology firm reported adjusted earnings of $0.54 per share, beating analyst expectations of $0.43, while revenue totaled $402.1 million, below the $414.23 million consensus.…